Advancing Diagnosis and Management of Atopic Dermatitis in Children and Adolescents Evaluation (ID: i717a) Question Title * 1. Following your participation in this activity, how confident are you in the management of patients with AD in your practice? Very confident Confident Neutral Unconfident Very unconfident Question Title * 2. How committed are you to making changes in your practice based on your participation in this activity? Very committed Committed Neutral Not committed I do not plan to make changes. Question Title * 3. How many patients with AD do you manage in your practice? Question Title * 4. Following participation in this activity, please select which of the following items you will include in patient education plans in your current practice. Written treatment plans Recommendation to moisturize frequently Information that topical medications do not take the place of moisturizers Importance of adherence Recommendation to continue maintenance treatments even when skin appears healthy Question Title * 5. After participating in today’s activity, I have improved knowledge of clinical data supporting use of new and emerging therapies for AD. Strongly agree Agree Neutral Disagree Strongly disagree Question Title * 6. As a result of participating in this activity, will you change components of your communication with patients with AD? If so, please describe changes. Question Title * 7. Which of the following best describes the impact of this activity on your performance? I gained new strategies/skills/information that I can apply to my area of practice I need more information before I change my practice behavior This activity will not change my practice, as my current practice is consistent with theinformation presented This activity will not change my practice, as I do not agree with the information presented Question Title * 8. After participating in today’s activity, I am now able to: Strongly agree Agree Neutral Disagree Strongly disagree Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Strongly agree Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Agree Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Neutral Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Disagree Review updated guidelines to accurately diagnose atopic dermatitis (AD) and make treatment decisions based on severity for children and adolescents Strongly disagree Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Strongly agree Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Agree Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Neutral Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Disagree Evaluate recent clinical evidence on the utility of approved and emerging biologic agents that treat moderate-to-severe AD Strongly disagree Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Strongly agree Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Agree Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Neutral Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Disagree Describe effectiveness of shared decision making in pediatric conditions and using action plan components to manage AD Strongly disagree Question Title * 9. Peter Lio, MD, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 10. Elaine Siegfried, MD, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 11. The content presented: Strongly agree Agree Neutral Disagree Strongly disagree Enhanced my current knowledge base Enhanced my current knowledge base Strongly agree Enhanced my current knowledge base Agree Enhanced my current knowledge base Neutral Enhanced my current knowledge base Disagree Enhanced my current knowledge base Strongly disagree Addressed my most pressing questions Addressed my most pressing questions Strongly agree Addressed my most pressing questions Agree Addressed my most pressing questions Neutral Addressed my most pressing questions Disagree Addressed my most pressing questions Strongly disagree Promoted improvements or quality in health care Promoted improvements or quality in health care Strongly agree Promoted improvements or quality in health care Agree Promoted improvements or quality in health care Neutral Promoted improvements or quality in health care Disagree Promoted improvements or quality in health care Strongly disagree Was scientifically rigorous and evidence based Was scientifically rigorous and evidence based Strongly agree Was scientifically rigorous and evidence based Agree Was scientifically rigorous and evidence based Neutral Was scientifically rigorous and evidence based Disagree Was scientifically rigorous and evidence based Strongly disagree Avoided commercial bias or influence Avoided commercial bias or influence Strongly agree Avoided commercial bias or influence Agree Avoided commercial bias or influence Neutral Avoided commercial bias or influence Disagree Avoided commercial bias or influence Strongly disagree Question Title * 12. What barriers do you see to making changes in your practice? Question Title * 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: Question Title * 14. If you indicated that you perceived commercial bias or influence, please describe: Question Title * 15. If you would like to participate in a text-message based Mobile Coach activity related to the content of this program, please provide your mobile number below. Yes, I would like to participate in the text-based Mobile Coach activity. Mobile Phone: Done